about
Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid CancerPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineSignaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsGenetic Testing in Differentiated Thyroid Carcinoma: Indications and Clinical ImplicationsTERT promoter mutations in thyroid cancerGenomically driven precision medicine to improve outcomes in anaplastic thyroid cancerMolecular Assays in Cytopathology for Thyroid CancerProgress in molecular-based management of differentiated thyroid cancerPersonalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsEmerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapyHighly prevalent TERT promoter mutations in aggressive thyroid cancers.BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrenceEtiopathogenesis of Differentiated Thyroid CarcinomasThe changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic reviewmiRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancersComputational characterisation of cancer molecular profiles derived using next generation sequencingIntegrated genomic characterization of papillary thyroid carcinomaNomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent TumorsIdentification of a recurrent STRN/ALK fusion in thyroid carcinomasThe Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter dataThe role of podoplanin in the biology of differentiated thyroid cancers.Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupFluorescence in situ hybridization in surgical pathology: principles and applications.Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).FOXD3 regulates anaplastic thyroid cancer progression.The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing.New insights into the diagnosis of nodular goiter.A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases.Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells.Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironmentAntitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer modelsMicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.RASAL1 in thyroid cancer: promise from a new friend.
P2860
Q26744936-B5AA1A07-23E8-4C36-BD12-00AA2117922CQ26748603-33C01ACE-0838-4630-A57B-FF7517142AF2Q26764899-95BEF85E-DE4A-4C19-B95D-5D90886469A6Q26765085-4B1ABF3B-215A-45FC-9703-0F28F908291BQ26770808-532FCF8D-D657-41EC-B22E-F03C654AE80EQ26820880-EDC02026-FD3D-48BA-9C11-320E6E442892Q26823658-0A88944C-2EEA-43FD-A204-B139044AA0BAQ26999887-E6677F5B-E23D-4357-94BB-7E5F61C061FBQ27027491-E5427FCA-2C65-40BF-904D-16CD911808BFQ27348342-12A77B9D-98D3-4FF1-A16F-9FC57087C8FFQ27852353-80084820-915C-411C-A4FC-6B8183158C12Q27853042-793264BE-0213-49E6-B020-35E2800B55C1Q28071277-0AB07475-D561-4A34-A37B-446528C34F8BQ28076196-173BA1ED-02D5-4371-BC30-75B1E3CA625EQ28078451-CA2F4D05-F570-4FA2-9294-6A73E2A90C47Q28080523-3EF2CAE9-AA31-4B7E-8874-83318FA705FBQ28251986-8D2573E7-49B5-4BD2-A910-0D2DDFF1CC26Q28274899-DF450CD8-8A41-4F8F-A708-FBF262ADF7A5Q28539208-D2FD50AF-1927-4DA5-AB51-2EB9C6579051Q30379880-95E26BA6-3CD8-4863-BFBC-64EF1E534C04Q30771291-5A80CF24-9138-4BB2-A303-A77238976555Q30825440-F7BE1CA4-8F7E-4AE3-9728-5FDB2F236B35Q33568168-C9CDFE67-0248-4339-AE9E-F785C99EB996Q33587905-AFBBB27E-9763-4FBD-AF99-6535E016EAE8Q33593910-F427ABEE-183E-4C97-AC99-8CFAC2339A39Q33624558-C5B271CA-73E4-4937-AD09-73F6E8D80CC8Q33771707-2B9C5DCD-D29A-42F8-A5A3-E8DAB39294ADQ33779603-78D906DA-DF58-4C8E-8499-600F3959771CQ33780921-91192DDF-1620-4CA7-8548-13F55D490AA3Q33827492-DA1086E9-BBD4-469A-B454-BA40CDA4973CQ33852864-012766F5-106E-4868-8132-619E7A0F2CB7Q33875906-66CE55BE-1F8C-491B-B175-5D351F0D71B2Q33890655-C8FAE0AB-0C5C-4931-88FF-EBD047C2BE2FQ33909333-72E7EE02-5135-4E08-901B-FD3545F2108CQ33931406-581FBDF2-5B0F-40AD-BA1E-4D471D45DA39Q34103836-58709623-5781-4FC5-BD41-34BB89628203Q34137706-6A68A821-0DF5-48C8-B8B1-8BD346DED907Q34253418-8ABDA550-EBEB-458F-B3D4-411F6D7FF260Q34259271-22E0413A-A40D-4032-9914-1F8D9D28FDB7Q34284826-969A2819-4C56-43F7-AF59-3FFB6AC70DEB
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Molecular pathogenesis and mechanisms of thyroid cancer
@ast
Molecular pathogenesis and mechanisms of thyroid cancer
@en
Molecular pathogenesis and mechanisms of thyroid cancer
@nl
type
label
Molecular pathogenesis and mechanisms of thyroid cancer
@ast
Molecular pathogenesis and mechanisms of thyroid cancer
@en
Molecular pathogenesis and mechanisms of thyroid cancer
@nl
prefLabel
Molecular pathogenesis and mechanisms of thyroid cancer
@ast
Molecular pathogenesis and mechanisms of thyroid cancer
@en
Molecular pathogenesis and mechanisms of thyroid cancer
@nl
P2860
P356
P1476
Molecular pathogenesis and mechanisms of thyroid cancer
@en
P2093
Mingzhao Xing
P2860
P2888
P304
P356
10.1038/NRC3431
P407
P577
2013-03-01T00:00:00Z
P5875
P6179
1009089021